Articles with public access mandates - Hiroyoshi TakeuchiLearn more
Not available anywhere: 39
Life satisfaction and happiness among young adults with schizophrenia
G Fervaha, O Agid, H Takeuchi, G Foussias, G Remington
Psychiatry Research 242, 174-179, 2016
Mandates: Canadian Institutes of Health Research
Clinical determinants of life satisfaction in chronic schizophrenia: data from the CATIE study
G Fervaha, O Agid, H Takeuchi, G Foussias, G Remington
Schizophrenia research 151 (1-3), 203-208, 2013
Mandates: US National Institutes of Health
Antipsychotic treatment in the maintenance phase of schizophrenia: an updated systematic review of the guidelines and algorithms
Y Shimomura, Y Kikuchi, T Suzuki, H Uchida, M Mimura, H Takeuchi
Schizophrenia Research 215, 8-16, 2020
Mandates: Canadian Institutes of Health Research
Depressive symptoms and small hippocampal volume accelerate the progression to dementia from mild cognitive impairment
JK Chung, E Plitman, S Nakajima, MM Chakravarty, F Caravaggio, ...
Journal of Alzheimer's Disease 49 (3), 743-754, 2016
Mandates: US National Institutes of Health, US Department of Veterans Affairs …
Clozapine response trajectories and predictors of non-response in treatment-resistant schizophrenia: a chart review study
P Shah, Y Iwata, EE Brown, J Kim, M Sanches, H Takeuchi, S Nakajima, ...
European Archives of Psychiatry and Clinical Neuroscience 270, 11-22, 2020
Mandates: Canadian Institutes of Health Research
Motivational deficits in major depressive disorder: cross-sectional and longitudinal relationships with functional impairment and subjective well-being
G Fervaha, G Foussias, H Takeuchi, O Agid, G Remington
Comprehensive psychiatry 66, 31-38, 2016
Mandates: US National Institutes of Health
Extrapyramidal symptoms and cognitive test performance in patients with schizophrenia
G Fervaha, O Agid, H Takeuchi, J Lee, G Foussias, KK Zakzanis, ...
Schizophrenia research 161 (2-3), 351-356, 2015
Mandates: US National Institutes of Health, Canadian Institutes of Health Research
Effect of antipsychotic medication on overall life satisfaction among individuals with chronic schizophrenia: findings from the NIMH CATIE study
G Fervaha, O Agid, H Takeuchi, G Foussias, G Remington
European neuropsychopharmacology 24 (7), 1078-1085, 2014
Mandates: US National Institutes of Health, Canadian Institutes of Health Research
Using poverty of speech as a case study to explore the overlap between negative symptoms and cognitive dysfunction
G Fervaha, H Takeuchi, G Foussias, O Agid, G Remington
Schizophrenia Research 176 (2-3), 411-416, 2016
Mandates: US National Institutes of Health, Canadian Institutes of Health Research
Examination of the validity of the Brief Neurocognitive Assessment (BNA) for schizophrenia
G Fervaha, C Hill, O Agid, H Takeuchi, G Foussias, I Siddiqui, RS Kern, ...
Schizophrenia research 166 (1-3), 304-309, 2015
Mandates: US National Institutes of Health, Canadian Institutes of Health Research
Neurocognitive impairment in the deficit subtype of schizophrenia
G Fervaha, O Agid, G Foussias, I Siddiqui, H Takeuchi, G Remington
European archives of psychiatry and clinical neuroscience 266, 397-407, 2016
Mandates: US National Institutes of Health, Canadian Institutes of Health Research
Adherence to clozapine vs. other antipsychotics in schizophrenia
H Takeuchi, C Borlido, M Sanches, C Teo, L Harber, O Agid, G Remington
Acta Psychiatrica Scandinavica 142 (2), 87-95, 2020
Mandates: Canadian Institutes of Health Research
Achievement motivation in early schizophrenia: Relationship with symptoms, cognition and functional outcome
G Fervaha, H Takeuchi, G Foussias, MK Hahn, O Agid, G Remington
Early intervention in psychiatry 12 (6), 1038-1044, 2018
Mandates: Canadian Institutes of Health Research
Clozapine administration in clinical practice: once‐daily versus divided dosing
H Takeuchi, V Powell, S Geisler, M DeSanti, G Fervaha, O Agid, JM Kane, ...
Acta Psychiatrica Scandinavica 134 (3), 234-240, 2016
Mandates: Canadian Institutes of Health Research
Measuring motivation in people with schizophrenia
G Fervaha, G Foussias, H Takeuchi, O Agid, G Remington
Schizophrenia Research 169 (1-3), 423-426, 2015
Mandates: Canadian Institutes of Health Research
Determinants of patient-rated and clinician-rated illness severity in schizophrenia
G Fervaha, H Takeuchi, O Agid, J Lee, G Foussias, G Remington
The Journal of Clinical Psychiatry 76 (7), 4299, 2015
Mandates: US National Institutes of Health
Predictors of clinical worsening after a switch to aripiprazole in patients with schizophrenia: a 1-year naturalistic follow-up study
H Takeuchi, H Uchida, T Suzuki, K Watanabe, H Kashima
Journal of clinical psychopharmacology 29 (4), 394-395, 2009
Mandates: US National Institutes of Health
Can aripiprazole worsen psychosis in schizophrenia? A meta-analysis of double-blind, randomized, controlled trials
H Takeuchi, A Fathi, S Thiyanavadivel, O Agid, G Remington
The Journal of Clinical Psychiatry 79 (2), 1313, 2018
Mandates: US National Institutes of Health, Canadian Institutes of Health Research
Impact of once-versus twice-daily perphenazine dosing on clinical outcomes: an analysis of the CATIE data
H Takeuchi, G Fervaha, H Uchida, T Suzuki, RR Bies, D Grönte, ...
The Journal of Clinical Psychiatry 75 (5), 8640, 2014
Mandates: US National Institutes of Health
Clinical and functional outcomes in people with schizophrenia with a high sense of well-being
G Fervaha, O Agid, H Takeuchi, G Foussias, J Lee, G Remington
The Journal of Nervous and Mental Disease 203 (3), 187-193, 2015
Mandates: US National Institutes of Health, Canadian Institutes of Health Research
Publication and funding information is determined automatically by a computer program